Please enable JavaScript to continue using this application.

Compare $ARWR vs $CYTK | Chartloom

Compare

$ARWR vs $CYTK

Arrowhead Pharmaceuticals Inc · Cytokinetics Inc

ARWR

Arrowhead Pharmaceuticals Inc

CYTK

Cytokinetics Inc

Compare $ARWR vs $CYTK

Comparing Arrowhead Pharmaceuticals Inc and Cytokinetics Inc

ARWRArrowhead Pharmaceuticals Inc

CYTKCytokinetics Inc

ARWRArrowhead Pharmaceuticals Inc

Market cap

$8.84B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

43.85x

Rev growth (TTM)

16.8%

YTD performance

-7.4%

52W performance

69.9%

FCF yield

-0.8%

CYTKCytokinetics Inc

Market cap

$8.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

33.61x

Rev growth (TTM)

-21.1%

YTD performance

1.9%

52W performance

3.4%

FCF yield

-6.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARWR

CYTK

Detailed metrics comparison

ARWR

Arrowhead Pharmaceuticals Inc

CYTK

Cytokinetics Inc

Market Cap

ARWR$8.84B

CYTK$8.53B

Enterprise Value

ARWR$10.04B

CYTK$9.42B

Price

ARWR$62.75

CYTK$62.91

P/E Ratio

ARWRN/A

CYTKN/A

P/S Ratio

ARWR13.20x

CYTK126.04x

EV/Sales

ARWR15.00x

CYTK139.22x

EV/EBITDA

ARWR31.55x

CYTK1,193.30x

P/B Ratio

ARWR19.48x

CYTK83.67x

P/FCF Ratio

ARWRN/A

CYTKN/A

EV/FCF

ARWR-133.73x

CYTK-16.22x

PEG Ratio

ARWRN/A

CYTKN/A

Forward P/E (NTM)

ARWRN/A

CYTKN/A

Forward P/S (NTM)

ARWR43.85x

CYTK33.61x

Revenue (TTM)

ARWR$669M

CYTK$68M

Revenue Growth (YoY)

ARWR16.8%

CYTK-21.1%

Forward Rev Growth

ARWR131.3%

CYTK183.7%

Gross Margin (TTM)

ARWR0.0%

CYTK58.9%

Operating Margin (TTM)

ARWR0.0%

CYTK0.0%

EBITDA Margin (TTM)

ARWR-30.0%

CYTK-1027.6%

Net Margin (TTM)

ARWR-47.8%

CYTK-1321.1%

FCF Margin (TTM)

ARWR-11.2%

CYTK-858.2%

Net Income (TTM)

ARWR$-320M

CYTK$-894M

FCF (TTM)

ARWR$-75M

CYTK$-581M

EPS (TTM)

ARWR-$2.23

CYTK-$6.77

ROE (TTM)

ARWR-6054.0%

CYTK-13119.0%

ROA (TTM)

ARWR-1737.0%

CYTK-5902.0%

ROIC (TTM)

ARWR-2193.0%

CYTK-1872.0%

Cash

ARWR$51M

CYTK$255M

Debt

ARWR$1.26B

CYTK$1.15B

Net Cash/Debt

ARWR$-1.21B

CYTK$-892M

Current Ratio (TTM)

ARWR5.90x

CYTK6.66x

Quick Ratio (TTM)

ARWR5.81x

CYTK6.56x

Debt/Equity (TTM)

ARWR2.70x

CYTK6.01x

Debt/Assets (TTM)

ARWR0.0%

CYTK0.0%

Interest Coverage (TTM)

ARWRN/A

CYTKN/A

Net Debt/EBITDA (TTM)

ARWR0.00x

CYTK0.00x

Beta

ARWR1.34

CYTK0.42

52W Performance

ARWR69.9%

CYTK3.4%

YTD Performance

ARWR-7.4%

CYTK1.9%

% from 52W High

ARWR-34.3%

CYTK-28.8%

% from 52W Low

ARWR81.3%

CYTK15.9%

Asset Turnover (TTM)

ARWR0.36x

CYTK0.04x

FCF Yield (TTM)

ARWR-0.8%

CYTK-6.8%

Earnings Yield (TTM)

ARWR-3.6%

CYTK-10.5%

Dividend Yield (TTM)

ARWRN/A

CYTKN/A

Rule of 40

ARWR5.6

CYTK-879.2

EV/GP/RG

ARWRN/A

CYTK0.73

Ticker research

View ARWR research View CYTK research

Metric	ARWR Arrowhead Pharmaceuticals Inc	CYTK Cytokinetics Inc
Market & Valuation
Market Cap	$8.84B	$8.53B
Enterprise Value	$10.04B	$9.42B
Price	$62.75	$62.91
P/E Ratio	N/A	N/A
P/S Ratio	13.20x	126.04x
EV/Sales	15.00x	139.22x
EV/EBITDA	31.55x	1,193.30x
P/B Ratio	19.48x	83.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-133.73x	-16.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	43.85x	33.61x
Revenue & Growth
Revenue (TTM)	$669M	$68M
Revenue Growth (YoY)	16.8%	-21.1%
Forward Rev Growth	131.3%	183.7%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-30.0%	-1027.6%
Net Margin (TTM)	-47.8%	-1321.1%
FCF Margin (TTM)	-11.2%	-858.2%
Net Income (TTM)	$-320M	$-894M
FCF (TTM)	$-75M	$-581M
EPS (TTM)	-$2.23	-$6.77
ROE (TTM)	-6054.0%	-13119.0%
ROA (TTM)	-1737.0%	-5902.0%
ROIC (TTM)	-2193.0%	-1872.0%
Financial Health
Cash	$51M	$255M
Debt	$1.26B	$1.15B
Net Cash/Debt	$-1.21B	$-892M
Current Ratio (TTM)	5.90x	6.66x
Quick Ratio (TTM)	5.81x	6.56x
Debt/Equity (TTM)	2.70x	6.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.34	0.42
52W Performance	69.9%	3.4%
YTD Performance	-7.4%	1.9%
% from 52W High	-34.3%	-28.8%
% from 52W Low	81.3%	15.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.04x
FCF Yield (TTM)	-0.8%	-6.8%
Earnings Yield (TTM)	-3.6%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.6	-879.2
EV/GP/RG	N/A	0.73
Ticker research	View ARWR research	View CYTK research

Valuation

P/S Ratio

ARWR

13.20x

CYTK

126.04x

EV/FCF

ARWR

-133.73x

CYTK

-16.22x

Growth & revenue

Revenue Growth TTM

ARWR

16.8%

CYTK

-21.1%

Forward Revenue Growth

CYTK

183.7%

ARWR

131.3%

Profitability & performance

Gross Margin

CYTK

58.9%

ARWR

0.0%

ROE

ARWR

-6054.0%

CYTK

-13119.0%

FCF Yield %

ARWR

-0.8%

CYTK

-6.8%

52-Week Performance

ARWR

69.9%

CYTK

3.4%

Detailed metrics comparison

ARWR

Arrowhead Pharmaceuticals Inc

CYTK

Cytokinetics Inc

Market Cap

ARWR$8.84B

CYTK$8.53B

Enterprise Value

ARWR$10.04B

CYTK$9.42B

Price

ARWR$62.75

CYTK$62.91

P/E Ratio

ARWRN/A

CYTKN/A

P/S Ratio

ARWR13.20x

CYTK126.04x

EV/Sales

ARWR15.00x

CYTK139.22x

EV/EBITDA

ARWR31.55x

CYTK1,193.30x

P/B Ratio

ARWR19.48x

CYTK83.67x

P/FCF Ratio

ARWRN/A

CYTKN/A

EV/FCF

ARWR-133.73x

CYTK-16.22x

PEG Ratio

ARWRN/A

CYTKN/A

Forward P/E (NTM)

ARWRN/A

CYTKN/A

Forward P/S (NTM)

ARWR43.85x

CYTK33.61x

Revenue (TTM)

ARWR$669M

CYTK$68M

Revenue Growth (YoY)

ARWR16.8%

CYTK-21.1%

Forward Rev Growth

ARWR131.3%

CYTK183.7%

Gross Margin (TTM)

ARWR0.0%

CYTK58.9%

Operating Margin (TTM)

ARWR0.0%

CYTK0.0%

EBITDA Margin (TTM)

ARWR-30.0%

CYTK-1027.6%

Net Margin (TTM)

ARWR-47.8%

CYTK-1321.1%

FCF Margin (TTM)

ARWR-11.2%

CYTK-858.2%

Net Income (TTM)

ARWR$-320M

CYTK$-894M

FCF (TTM)

ARWR$-75M

CYTK$-581M

EPS (TTM)

ARWR-$2.23

CYTK-$6.77

ROE (TTM)

ARWR-6054.0%

CYTK-13119.0%

ROA (TTM)

ARWR-1737.0%

CYTK-5902.0%

ROIC (TTM)

ARWR-2193.0%

CYTK-1872.0%

Cash

ARWR$51M

CYTK$255M

Debt

ARWR$1.26B

CYTK$1.15B

Net Cash/Debt

ARWR$-1.21B

CYTK$-892M

Current Ratio (TTM)

ARWR5.90x

CYTK6.66x

Quick Ratio (TTM)

ARWR5.81x

CYTK6.56x

Debt/Equity (TTM)

ARWR2.70x

CYTK6.01x

Debt/Assets (TTM)

ARWR0.0%

CYTK0.0%

Interest Coverage (TTM)

ARWRN/A

CYTKN/A

Net Debt/EBITDA (TTM)

ARWR0.00x

CYTK0.00x

Beta

ARWR1.34

CYTK0.42

52W Performance

ARWR69.9%

CYTK3.4%

YTD Performance

ARWR-7.4%

CYTK1.9%

% from 52W High

ARWR-34.3%

CYTK-28.8%

% from 52W Low

ARWR81.3%

CYTK15.9%

Asset Turnover (TTM)

ARWR0.36x

CYTK0.04x

FCF Yield (TTM)

ARWR-0.8%

CYTK-6.8%

Earnings Yield (TTM)

ARWR-3.6%

CYTK-10.5%

Dividend Yield (TTM)

ARWRN/A

CYTKN/A

Rule of 40

ARWR5.6

CYTK-879.2

EV/GP/RG

ARWRN/A

CYTK0.73

Ticker research

View ARWR research View CYTK research

Metric	ARWR Arrowhead Pharmaceuticals Inc	CYTK Cytokinetics Inc
Market & Valuation
Market Cap	$8.84B	$8.53B
Enterprise Value	$10.04B	$9.42B
Price	$62.75	$62.91
P/E Ratio	N/A	N/A
P/S Ratio	13.20x	126.04x
EV/Sales	15.00x	139.22x
EV/EBITDA	31.55x	1,193.30x
P/B Ratio	19.48x	83.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-133.73x	-16.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	43.85x	33.61x
Revenue & Growth
Revenue (TTM)	$669M	$68M
Revenue Growth (YoY)	16.8%	-21.1%
Forward Rev Growth	131.3%	183.7%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-30.0%	-1027.6%
Net Margin (TTM)	-47.8%	-1321.1%
FCF Margin (TTM)	-11.2%	-858.2%
Net Income (TTM)	$-320M	$-894M
FCF (TTM)	$-75M	$-581M
EPS (TTM)	-$2.23	-$6.77
ROE (TTM)	-6054.0%	-13119.0%
ROA (TTM)	-1737.0%	-5902.0%
ROIC (TTM)	-2193.0%	-1872.0%
Financial Health
Cash	$51M	$255M
Debt	$1.26B	$1.15B
Net Cash/Debt	$-1.21B	$-892M
Current Ratio (TTM)	5.90x	6.66x
Quick Ratio (TTM)	5.81x	6.56x
Debt/Equity (TTM)	2.70x	6.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.34	0.42
52W Performance	69.9%	3.4%
YTD Performance	-7.4%	1.9%
% from 52W High	-34.3%	-28.8%
% from 52W Low	81.3%	15.9%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.04x
FCF Yield (TTM)	-0.8%	-6.8%
Earnings Yield (TTM)	-3.6%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.6	-879.2
EV/GP/RG	N/A	0.73
Ticker research	View ARWR research	View CYTK research